Form 4 for GH Guardant Health, Inc.
Accepted 2023-10-02 00:00:00 ET · period of report 2023-10-01 · accession 0001576280-23-000169 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-02 | 2023-10-01 | GH | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | +7,713 | 15.4K | +100% | $0 |
| D | 2023-10-02 | 2023-10-01 | GH | Freeman Chris | Chief Commercial Off | F - Tax | $29.64 | -2,128 | 13.3K | -14% | -$63.1K |
| D | 2023-10-02 | 2023-10-01 | GH | Freeman Chris | Chief Commercial Off | M - OptEx | $0.00 | -7,713 | 23.1K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2023-10-01 | M | A | 7,713 | $0.00 | 15,407 | D | — | — | |
| 2 | Common | COMMON STOCK | 2023-10-01 | F | D | 2,128 | $29.64 | 13,279 | D | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 3 | Derivative | RESTRICTED STOCK UNITS | 2023-10-01 | M | D | 7,713 | $0.00 | 23,141 | D | $0.00 · — to — | 7,713 COMMON STOCK | (F2) This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. (F3) Not applicable for Restricted Stock Units. |